| 7411072 |
Tricyclic steroid hormone nuclear receptor modulators |
Michael J. Coghlan, Jonathan Edward Green, Timothy A. Grese, Prabhakar Kondaji Jadhav, Donald P. Matthews +2 more |
2008-08-12 |
$92,020,000 |
| 7250442 |
Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators |
Matthew Brown, Timothy A. Grese, Prabhakar Kondaji Jadhav, David Andrew Neel, Peter Ambrose Lander |
2007-07-31 |
$79,905,000 |
| 6610680 |
Non-peptidyl vasopressin V1A antagonists |
Robert F. Bruns, Jr., Robin D G Cooper, Bruce A. Dressman, David C. Hunden, Stephen W. Kaldor +3 more |
2003-08-26 |
$115,876,000 |
| 6521611 |
Non-peptidyl vasopressin V1a antagonists |
Robert F. Bruns, Jr., Robin D G Cooper, Bruce A. Dressman, David C. Hunden, Stephen W. Kaldor +3 more |
2003-02-18 |
$148,484,000 |
| 6204260 |
Non-peptidyl vasopressin V1a antagonists |
Robert F. Bruns, Jr., Robin D G Cooper, Bruce A. Dressman, David C. Hunden, Stephen W. Kaldor +3 more |
2001-03-20 |
$1,153,187,000 |
| 5914235 |
Potentiation of .sup.3 H! 2-(2-benzofuranyl)-2-imidazoline (BFI) binding sites in human tissue by tranylcypromine (TCP) |
Sally Ann Wiest |
1999-06-22 |
$124,310,000 |
| 5846973 |
Methods of treating pulmonary hypertension |
Donald R. Gehlert |
1998-12-08 |
$178,932,000 |
| 5732717 |
Method for treating substance abuse withdrawal |
August Masaru Watanabe, Thomas F. Bumol, Mary Jeanne Kallman, Kurt Rasmussen |
1998-03-31 |
$86,352,000 |
| 5693633 |
Angiotensin II antagonists |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1997-12-02 |
$77,823,000 |
| 5612360 |
Angiotensin II antagonists |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1997-03-18 |
$65,116,000 |
| 5571925 |
Angiotensin II antagonists |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Richard L. Simon +1 more |
1996-11-05 |
$72,135,000 |
| 5569768 |
Angiotensin II antagonists |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1996-10-29 |
$52,853,000 |
| 5563278 |
Angiotensin II antagonists |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Richard L. Simon +1 more |
1996-10-08 |
$20,245,000 |
| 5556981 |
Angiotensin II antagonist intermediates |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1996-09-17 |
$60,282,000 |
| 5484780 |
Angiotensin II antagonists |
Donald B. Boyd, Kenneth Lee Hauser, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz +6 more |
1996-01-16 |
$19,679,000 |
| 5401851 |
Angiotensin II antagonists |
Donald B. Boyd, Kenneth Lee Hauser, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz +6 more |
1995-03-28 |
$40,430,000 |
| 5312936 |
Angiotensin II antagonists |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Richard L. Simon +1 more |
1994-05-17 |
$48,226,000 |
| 5264445 |
"(-)-N""-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine" |
David W. Robertson |
1993-11-23 |
$32,945,000 |
| 5073566 |
Angiotensin II antagonist 1,3-imidazoles and use thereas |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Richard L. Simon +1 more |
1991-12-17 |
$106,888,000 |
| 4596827 |
Alkylsulfonamidophenylalkylamine compounds used for treating arrhythmia |
Bryan B. Molloy |
1986-06-24 |
$31,631,000 |
| 4569801 |
Alkylsulfonamidophenylalkylamines |
Bryan B. Molloy |
1986-02-11 |
$7,349,000 |
| 4528177 |
Imaging agents and method |
Bryan B. Molloy |
1985-07-09 |
$8,552,000 |
| 4395410 |
Quaternary ammonium antiarrhythmic drugs |
Bryan B. Molloy |
1983-07-26 |
$14,478,000 |
| 4336269 |
Para-nitrophenylalkylamines |
Bryan B. Molloy |
1982-06-22 |
$2,984,000 |
| 4289787 |
Quaternary ammonium antiarrhythmic drugs |
Bryan B. Molloy |
1981-09-15 |
$2,490,000 |
